Journal of Medicinal Chemistry · 2008 · 39 citations · 25 references
PharmacyChemistryMedicinal ChemistryDrug DesignDrug DiscoverySynthetic Medicinal ChemistryAntiviral AgentsEnzyme InhibitionLigand BindingLigand-based DesignMolecular DockingProtein-ligand DockingAntiviral Drug DesignAntiviral Structure-activity RelationshipsBinding Mode AnalysisDocking-based Drug DesignEnzymatic InhibitionFluorine ChemistryIntegrase Strand Transfer InhibitorsMolecular Docking Of Inhibitors
A new model of HIV-1 integrase-Mg-DNA complex that is useful for docking experiments has been built. It was used to study the binding mode of integrase strand transfer inhibitor 1 (CHI-1043) and other fluorine analogues. Molecular modeling results prompted us to synthesize the designed derivatives which showed potent enzymatic inhibition at nanomolar concentration, high antiviral activity, and low toxicity. Microwave assisted organic synthesis (MAOS) was employed in several steps of the synthetic pathway, thus reducing reaction times and improving yields.
25